I wrote a short interactive article👆
It uses simulations to demonstrate how different cardiac arrhythmias can develop.
Try it out! (It has defibrillators ⚡️)
jenevoldsen.com/posts/excitable-cells
#medsky #cardiosky #cccsky #emimcc
Yes, just curious re the axis/transition which fused with fig. 3 to make fig 1&2
Very nice. How'd the intrinsic look?
Very cool! Any thoughts on an RV pacing control? Would also be interesting if QRS area better corresponded to the metabolic effect of CRT as it does with hemodyanmics
onlinelibrary.wiley.com/doi/10.1111/...
Have seen the same with patulous esophagus. Have a CT? www.sciencedirect.com/science/arti...
www.jacc.org/doi/10.1016/...
Interesting early experience for MR guided radiotherapy for refractory septal VT. #EPeeps #CardioSky
LA/RL makes III across the legs which is low but not no vector. If II=-III then aVF is 0.
#EPeeps Okay I thought I knew all the limb lead reversal patterns, but what madness is this?
I believe the math works if the limb leads lie in (or nearly in) the same line with LL midway between LA and RA so that II and III are mirror images (ie. II=-III)? This is consistent with aVF=(II+III)/2 =0 and aVL=(I -III)/2= (I+II)/2=-aVR.
link.springer.com/article/10.1...
Increasingly compelling data for persistent AF/HFrEF pts to receive early rhythm control. Also RACE II rate control definitions may not be completely adequate. #CardioSky #EPeeps
SGLT2 inhibitors exert cardioprotective effects in heart failure but the role of ketone oxidation has been debated.
Goedeke et al. used sophisticated tracer experiments to evaluate the effects of SGLT inhibitors on cardiac metabolism in models: https://www.jci.org/articles/view/176708
Presented at #AHA24 Late Breaking session, we are pleased to announce #PanEcho - Complete AI-enabled echocardiography interpretation with multi-task deep learning.
Led by @giholste.bsky.social & @ekoikonomou.bsky.social
@cardslab.bsky.social
Preprint, code, and model: cards-lab.org/panecho
You used to call me on my self-own
Any programmed stim attempts from LV?
Fantastic presentation from Mina Chung on the results of the TRIM-AF study.
RFM +/- Metformin had benefit in symptoms but no benefit on AF burden.
Congratulations to @omwazni and the OPTION study team on the @ahascience.bsky.social presentation and publication of the OPTION trial.
Similar low rates of stroke post ablation (no difference with laao vs OAC) with no significant 23% lower rate of major bleeding.
www.nejm.org/doi/full/10....
